MedTrace Logo

Stroke Upper Limb Rehabilitation With Robot Operators: a Synergistic Approach for Human-Robot Interaction and Rehabilitative Trials.

NCT07768683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-08-17

No results posted yet for this study

Summary

In clinical scenario, clinical scales and kinematic analysis are usually used for the evaluation of patients. However, these methods are limited, since they may suffer from the lack of objectivity and sensitivity. Synergies go beyond pure kinematics and allow to directly understand the neural mechanisms underlying the motor impairment. Synergy analysis has been exploited for understanding physiological mechanisms in healthy subjects, but only few studies analyzed muscle synergies on patients during rehabilitation. In order to translate this methodology to the clinical practice, there is the need of comprehensive and structured studies. However, only few pilot studies are available that analyzed synergies during rehabilitation. Thus, in this study we aimed at filling this gap by analyzing synergies during human-robot interaction when using an end-effector robot and an exoskeleton robot and by assessing in detail the modifications of synergies after robotic rehabilitation.

Conditions

Interventions

DEVICE

Upper Limb robotic training

30 minutes daily sessions using study upper limb robot, 3 days a week for 4 consecutive weeks, for a total of 12 sessions.

Sponsors & Collaborators

  • STIIMA-Consiglio Nazionale delle Ricerche (CNR)

    collaborator UNKNOWN

  • Villa Beretta Rehabilitation Center

    lead OTHER

Principal Investigators

  • Franco Molteni, MD · Villa Beretta Rehabilitation Center- Valduce Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-08
Primary Completion
2026-05-12
Completion
2026-05-12

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07768683 on ClinicalTrials.gov